MOLINA HEALTHCARE, INC.
In the published model solve dated 2026-Q2, anchored at $195.01, MOLINA HEALTHCARE, INC. (MOH) is priced for 14.4% return on equity. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. The narrative was composed June 27, 2026 from SEC EDGAR filings.
At $195.62 the market is reading Molina the way an insurer should be read, off book value, not an operating multiple. The price implies a sustained return on equity of roughly 14.9% at about 2.5x book, against the roughly 11.6% it has earned recently. That is an above-trend but not extreme bet, and the model calls it within range. The near-term pressure is real. Medicaid carries about 83% of the business and the segment is being squeezed as state rate updates lag rising medical costs. Trailing
Is MOH overvalued? See what's priced in →
507 institutional managers reported holding MOH in 13F filings for the quarter ended 2026-03-31. 117 opened new positions that quarter. Held by BlackRock, Vanguard Group, FMR (Fidelity), among others. On the short side, 3.0M shares were sold short as of the 2026-06-15 count, about 6% of shares outstanding (3 days of typical volume to cover).
Quarterly 13F filings arrive up to 45 days after quarter end, so the picture is never current (filed through 2026-05-29). Nothing here is investment advice.
MOH has cut its share count 11.8% over the past five years, spending $2.40B on repurchases. It pays no dividend. Cash returned over the past three years: $2.00B in repurchases.
Share counts are split-adjusted; repurchase totals are gross of share issuance. Nothing here is investment advice.
Open-market insider buys at MOH over the trailing three years: 2025: 2 buys totaling $1.56M; 2026: 1 buy totaling $100k. 15 officers and directors are on file.
Code P open-market purchases from SEC Form 4 filings, non-derivative, excluding scheduled 10b5-1 plans. Nothing here is investment advice.
MOH's recent reports: the day-one move, then what the following quarter actually did.
| report | day one | next quarter |
|---|---|---|
| 2023-07-28 | -2.6% | +8.8% |
| 2023-10-27 | -0.7% | +7.5% |
| 2024-02-14 | +6.8% | -10.0% |
| 2024-04-26 | -3.0% | -13.1% |
Day-one is the close-to-close move around the filing. Nothing here is investment advice.
MOH's latest 8-K filings: 2026-07-22 (items 2.02, 9.01); 2026-06-10 (items 7.01, 9.01); 2026-05-11 (items 5.02, 5.03, 5.07, 9.01); 2026-05-08 (items 7.01, 9.01); 2026-04-22 (items 2.02, 9.01).
Item codes are the SEC's own classification of what each report discloses. Dates link to the filing on EDGAR. Nothing here is investment advice.
Model solve date: 2026-Q2
Narrative composed: June 27, 2026
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.